In 2006, frustrated by the lack of research and treatment options for patients with ependymoma, Mark Gilbert, M.D., deputy chair of the Department of Neuro-Oncology at MD Anderson, proposed creating an international group to develop new treatments for this rare type of brain tumor.
Under Gilbert's guidance, the Collaborative Ependymoma Research Network (CERN) Foundation was established with the mission of developing...
Cancerwise
Read stories from survivors and caregivers, and get MD Anderson experts’ insights on cancer treatment, research breakthroughs, healthy living and more.